SCHEMBL27205294

SCHEMBL27205294

NC(=O)c1n[nH]c(C2=NNC=CC=C2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3969262 0.67
SCHEMBL5155602 0.66 BCAT2 (0.45)
Hydrochloric Acid SCHEMBL3963502 0.65
SCHEMBL9107642 0.65 CYP1A2 (0.59)
SCHEMBL3822832 0.63 ALPL (0.57)
SCHEMBL19641487 0.61
SCHEMBL27571730 0.61 ALPL (0.48)
SCHEMBL3224791 0.60
SCHEMBL30332207 0.60
Pyrrole SCHEMBL18797670 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-B1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES HOFFMANN LA ROCHE (CH) 2024-03-27 EP disclosed